Concurrent Use of Opioids and Benzodiazepines in Cancer Pain - Risks and Alternatives
Concurrent Use of Opioids and Benzodiazepines in Cancer Pain - Risks and Alternatives is organized by The University of Texas MD Anderson Cancer Center.
Starting Date: June 8, 2023
Ending Date: June 7, 2025
Overview:
This activity will offer safe and appropriate use of opioids for cancer pain, which is of utmost importance in view of the national opioid crisis. Clinicians are required to act as gatekeepers by mitigating the potential harms associated with inappropriate opioid use while ensuring their rational and effective use in the treatment of cancer pain. This is possible when they utilize opportunities to enhance their knowledge and competencies in the use of opioids. This Pain and Opioid enduring material seek to provide healthcare providers the unique opportunity to achieve such competencies in their careers.
Objectives:
At the conclusion of this activity, learners will be able to:
• Assess the potential risks and adverse effects associated with concurrent use of opioids and benzodiazepines in cancer pain management to enhance patient safety.
• Evaluate and recommend alternative strategies for managing cancer pain that minimize the reliance on concurrent use of opioids and benzodiazepines.
• Examine evidence-based guidelines and best practices for prescribing opioids and benzodiazepines in cancer patients, emphasizing the significance of safe and appropriate utilization.
Additional details will be posted as soon as information is available.